Your browser doesn't support javascript.
loading
Efficacy and safety of 30-mg fimasartan for the treatment of patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, phase III clinical study.
Youn, Jong-Chan; Ihm, Sang-Hyun; Bae, Jang-Ho; Park, Seong-Mi; Jeon, Dong Woon; Jung, Byung-Chun; Park, Tae Ho; Lee, Nae Hee; Song, Jong-Min; Yoon, Young Won; Shin, Eun Seok; Sung, Ki Chul; Jung, In Hyun; Pyun, Wook Bum; Joo, Seung-Jae; Park, Woo Jung; Shin, Jin Ho; Kang, Seok-Min.
Afiliação
  • Youn JC; Division of Cardiology, Severance Cardiovascular Hospital and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Ihm SH; Division of Cardiology, Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, South Korea.
  • Bae JH; Division of Cardiology, Heart Center, Konyang University Hospital, Daejon, South Korea.
  • Park SM; Division of Cardiology, Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
  • Jeon DW; Division of Cardiology, National Health Insurance Corporation Ilsan Hospital, Goyang, South Korea.
  • Jung BC; Division of Cardiology, Daegu Fatima Hospital, Daegu, Korea.
  • Park TH; Department of Cardiology, Dong-A University Hospital, Busan, South Korea.
  • Lee NH; Division of Cardiology, Soonchunhyang University Hospital, Bucheon, South Korea.
  • Song JM; Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Yoon YW; Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Shin ES; Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Sung KC; Division of Cardiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Jung IH; Department of Internal Medicine, Sejong General Hospital, Bucheon, South Korea.
  • Pyun WB; Division of Cardiology, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
  • Joo SJ; Divison of Cardiology, Jeju National University Hospital, University of Jeju School of Medicine, Jeju, South Korea.
  • Park WJ; Division of Cardiology, Hallym University Sacred Heart Hospital, Anyang, South Korea.
  • Shin JH; Division of Cardiology, Hanyang University Hospital, Seoul, South Korea.
  • Kang SM; Division of Cardiology, Severance Cardiovascular Hospital and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: smkang@yuhs.ac.
Clin Ther ; 36(10): 1412-21, 2014 Oct 01.
Article em En | MEDLINE | ID: mdl-25092393
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Tetrazóis / Compostos de Bifenilo / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Tetrazóis / Compostos de Bifenilo / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Estados Unidos